TrialEuropean journal of drug metabolism and pharmacokinetics2017

Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study.

Yani Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.